The major dermatomyositis-specific Mi-2 autoantigen is a presumed helicase involved in transcriptional activation
about
Chromatin deacetylation by an ATP-dependent nucleosome remodelling complexCharacterization of the CHD family of proteinsWHSC1, a 90 kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf-Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myelomaIdentification and functional characterization of the p66/p68 components of the MeCP1 complex.The NuRD architectureNA14 is a novel nuclear autoantigen with a coiled-coil domainThe human Mi-2/NuRD complex and gene regulationDifferent Mi-2 complexes for various developmental functions in Caenorhabditis elegansDe Novo Mutations in CHD4, an ATP-Dependent Chromatin Remodeler Gene, Cause an Intellectual Disability Syndrome with Distinctive DysmorphismsdMi-2 and ISWI chromatin remodelling factors have distinct nucleosome binding and mobilization properties.Identification of autoantibodies elicited in a patient with prostate cancer presenting as dermatomyositis.The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth.Molecular cloning and characterization of OsCHR4, a rice chromatin-remodeling factor required for early chloroplast development in adaxial mesophyll.A mutation in the mouse Chd2 chromatin remodeling enzyme results in a complex renal phenotype.The NuRD chromatin-remodeling complex regulates signaling and repair of DNA damageAn ikaros-containing chromatin-remodeling complex in adult-type erythroid cells.Chromatin modification and diseaseAntibodies targeting extractable nuclear antigens: historical development and current knowledge.CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system.ATP-dependent chromatin remodeling: genetics, genomics and mechanisms.Myositis-specific autoantibodies: detection and clinical associations.Autoantibody profiles in the sera of European patients with myositis.The Chd family of chromatin remodelers.How many remodelers does it take to make a brain? Diverse and cooperative roles of ATP-dependent chromatin-remodeling complexes in development.Keeping things quiet: roles of NuRD and Sin3 co-repressor complexes during mammalian development.Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.CHD4 in the DNA-damage response and cell cycle progression: not so NuRDy nowStructure and function insights into the NuRD chromatin remodeling complex.Mi2, an auto-antigen for dermatomyositis, is an ATP-dependent nucleosome remodeling factor.Expression of the dermatomyositis autoantigen Mi-2 in regenerating muscle.The mouse Aire gene: comparative genomic sequencing, gene organization, and expression.Molecular mechanisms of OLIG2 transcription factor in brain cancer.Identification of multiple distinct Snf2 subfamilies with conserved structural motifs.Concerted action of the PHD, chromo and motor domains regulates the human chromatin remodelling ATPase CHD4.(1)H, (13)C, and (15)N resonance assignments for the tandem PHD finger motifs of human CHD4.Expression profiling of glucocorticoid-treated T-ALL cell lines: rapid repression of multiple genes involved in RNA-, protein- and nucleotide synthesis.Association of the chromodomain helicase DNA-binding protein 4 (CHD4) missense variation p.D140E with cancer: potential interaction with smoking.CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.Humoral aspects of polymyositis/dermatomyositis.Anisoosmotic regulation of the Mi-2 autoantigen mRNA in H4IIE rat hepatoma cells and primary hepatocytes.
P2860
Q22004265-8BB9CFA3-86DD-4FA3-9D4F-35D0DA7065C4Q24317090-C9040282-9E12-4A87-89D3-150C6F33797EQ24322575-E521F8D8-EE68-403D-9A7E-CCE134B56D5CQ24540055-1FEFFC07-9AF7-4F6C-8513-6CE1268D4182Q26865710-CD46A238-29FE-4BF2-AB9E-58A76E20676DQ28116660-CA11DE2E-2114-4042-A78B-73922E6178CCQ28240457-64AAA59F-B364-4CC3-86EA-670E41BE42E4Q28475938-506C1E6D-1EBC-4549-BD30-CA5745ECC192Q29147465-F8F6FDA8-8F2C-4E44-999E-9F4675931F30Q30607978-03BDB9BA-C87D-4848-B51B-F0BB1CC11653Q33241382-03055B1F-A9A9-49A3-A35A-27E21BD27822Q33292242-2D7DD8A6-A4CD-4840-B4D3-8DE81D24B8D8Q33353635-1AF2B038-6D22-4C6A-97A9-0BCDB38B3FDEQ33637832-276AA33D-821B-4ABC-AD4F-DCF972F77EB9Q33678587-E7BF1C73-6628-4A4C-9E67-4A8DBF6699CAQ33965887-1EA5E1D0-2749-42D8-ABB3-8EA1CF681D93Q34098840-44162EF9-D6E9-468B-90B6-D2EFB3035E12Q34119034-D14CC047-56D4-4F49-B7A8-5E645F2DFAA9Q34178216-93F11073-FA43-4251-9C13-E7F7FCFBA0CEQ34627244-5E97E727-BB90-4AFE-BDCE-8E511A8C8BAEQ35309808-783754E5-E21D-4DEC-91D5-9B6356ED7C18Q35550062-6B8990D5-2303-42AB-8366-863D11D331B8Q36756815-D50BC7DD-CDE2-4783-A7B6-71E553961BC9Q36916651-F726E344-3890-4533-8571-DC6FA9B13B5FQ37262437-0766AAF7-513F-4191-9DFD-F4109CCDF5BAQ37886653-36D2F7B8-1A0B-4DD5-BC8C-A6F30362D323Q38108666-4AAC5F0B-0354-4AC9-80A9-9781D390FF35Q38386331-61691A80-97AD-437D-85C0-E955AB7620CAQ39094708-B730F545-C62C-412E-89E1-9BC34281C0A2Q39288750-2778447C-252E-45FB-AF5B-55BF9EB49846Q40413305-A7E848A1-21B3-46CB-B911-A6FB57E49365Q41810203-A9A1BECD-2E74-42C9-94CB-0B59B5C41B3FQ41900203-592249D6-B6A2-449B-9810-6B48BF5E342DQ42413014-7117BCF3-9E0C-4204-83EE-D02F89CC626CQ42583186-2F5CCCB9-20AC-426B-964B-1CA42F285BDEQ43683791-0A296C1C-55E4-4A6B-B2F5-DFCD6514D0AEQ44329200-E8040631-9464-4EF5-9857-B1E9D13E19A0Q47699315-72D2CB64-C671-4213-893F-274F57CE036FQ47702950-DAA07F68-9371-475E-81E8-A9A8207D489BQ48019328-FF26B3B5-E867-4632-983D-56EBA76DC848
P2860
The major dermatomyositis-specific Mi-2 autoantigen is a presumed helicase involved in transcriptional activation
description
1995 nî lūn-bûn
@nan
1995 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
The major dermatomyositis-spec ...... in transcriptional activation
@ast
The major dermatomyositis-spec ...... in transcriptional activation
@en
The major dermatomyositis-spec ...... in transcriptional activation
@nl
type
label
The major dermatomyositis-spec ...... in transcriptional activation
@ast
The major dermatomyositis-spec ...... in transcriptional activation
@en
The major dermatomyositis-spec ...... in transcriptional activation
@nl
prefLabel
The major dermatomyositis-spec ...... in transcriptional activation
@ast
The major dermatomyositis-spec ...... in transcriptional activation
@en
The major dermatomyositis-spec ...... in transcriptional activation
@nl
P2093
P3181
P356
P1476
The major dermatomyositis-spec ...... in transcriptional activation
@en
P2093
P304
P3181
P356
10.1002/ART.1780381006
P407
P577
1995-10-01T00:00:00Z